ThermoStem™ Program (Brown Fat Stem Cells)
Potential Treatments for Preventing Type 2 Diabetes and Obesity
BRT’s ThermoStem™ Program is designed to develop treatments using brown fat stem cells for metabolic disorders and obesity focusing on potentially preventing the onset of Type 2 Diabetes. Additionally, we have identified the first stem cell population isolated from a particular brown adipose (fat) depot in humans.
Recent studies show that brown fat is present in the human body and has the ability to maintain and regulate metabolism. Potential use may include inducing weight loss (“biologic diet”) and the reduction of glucose and lipids – perhaps even leading to delaying or preventing the onset of Type 2 Diabetes.
As our brown fat cellular program advances, there is the opportunity to develop and collect data that may lead to the creation of a small molecule drug therapy (pharmaceutical) for the treatment of obesity and Type 2 Diabetes.
Brown fat stem cells may have many other advantages and our ThermoStem™ Program plans on leveraging this groundbreaking research into different cellular therapies.